Sobi
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA. Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world.
Recent news mentioning Sobi
- — Sobi has completed an issue of class C shares
- — Sobi has completed an issue of class C shares
- — Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
- — Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
- — BioNTech taps Sobi executive Oelkers as its next CEO
- — Guido Oelkers to step down as CEO of Sobi in the beginning of 2027
- — Guido Oelkers to step down as CEO of Sobi in the beginning of 2027